• 
  Mark van Barele, Delal Akdeniz, Bernadette a M Heemskerk-Gerritsen, Nadine Andrieu, Catherine Noguès, et al.. Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation. JNCI: Journal of the National Cancer Institute, 2024, 115, pp.1318 - 1328. ⟨10.1093/jnci/djad116⟩. ⟨inserm-04545755⟩
• 
  A. Verger, T. Horowitz, F. Le Jeune, C. Prunier-Aesh, S. Querellou, et al.. Clinical authorization of amyloid PET in France: Towards a more precise diagnosis of Alzheimer's disease. Journal de Biophysique et Medecine Nucleaire, 2023, 47 (4), pp.175-178. ⟨10.1016/j.mednuc.2023.03.002⟩. ⟨hal-04415555⟩
• 
  Pauline Rimmelé, Michela Esposito, Laure Delestré, Jean-Hugues Guervilly, Maya Ridinger-Saison, et al.. The Spi1/PU.1 transcription factor accelerates replication fork progression by increasing PP1 phosphatase in leukemia. Oncotarget, 2017, 8 (23), ⟨10.18632/oncotarget.16183⟩. ⟨hal-02424493⟩
• 
  Carolina Velazquez, Esin Orhan, Imene Tabet, Lise Fenou, Béatrice Orsetti, et al.. BRCA1-methylated triple negative breast cancers previously exposed to neoadjuvant chemotherapy form RAD51 foci and respond poorly to olaparib. Frontiers in Oncology, 2023, 13, pp.1125021. ⟨10.3389/fonc.2023.1125021⟩. ⟨hal-04275543⟩
• 
  Justine Gantzer, Maud Toulmonde, François Séverac, Ali N. Chamseddine, Celine Charon-Barra, et al.. PEC-PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intent. Cancer, 2024, ⟨10.1002/cncr.35277⟩. ⟨hal-04533834⟩
• 
  Sophie Leboulleux, Daniele Benisvy, David Taieb, Marie Attard, Claire Bournaud, et al.. MERAIODE: A Phase II Redifferentiation Trial with Trametinib and 131I in Metastatic Radioactive Iodine Refractory RAS Mutated Differentiated Thyroid Cancer. Thyroid, 2023, 33 (9), pp.1124-1129. ⟨10.1089/thy.2023.0240⟩. ⟨inserm-04527070⟩
• 
  Arnaud Bayle, Laila Belcaid, Lola-Jade Palmieri, Diego Teysonneau, Sophie Cousin, et al.. Circulating tumor DNA landscape and prognostic impact of acquired resistance to targeted therapies in cancer patients: a national center for precision medicine (PRISM) study. Molecular Cancer, 2023, 22 (1), pp.176. ⟨10.1186/s12943-023-01878-9⟩. ⟨inserm-04521346⟩
• 
  Alicia Rovó, Luuk Gras, Brian Piepenbroek, Nicolaus Kröger, H. Christian Reinhardt, et al.. Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT.. American Journal of Hematology, 2023, American Journal of Hematology, ⟨10.1002/ajh.27150⟩. ⟨hal-04510879⟩
• 
  Sebastien Salas, Guillaume Economos, Damien Hugues, Elise Gilbert, Dominique Gracia, et al.. Legalisation of euthanasia and assisted suicide: advanced cancer patient opinions – cross-sectional multicentre study. BMJ Palliative and supportive care, 2023, 13 (e3), pp.e1335-e1341. ⟨10.1136/spcare-2022-004134⟩. ⟨hal-04382168⟩
• 
  Xavier Pivot, Gilles Romieu, Pierre Fumoleau, Maria Rios, Hervé Bonnefoi, et al.. Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort. npj Breast Cancer, 2017, 3 (1), pp.4. ⟨10.1038/s41523-017-0005-y⟩. ⟨cea-04501580⟩
• 
  Elsa Nigon, Claudia Lefeuvre-Plesse, Alejandra Martinez, Céline Chauleur, Alain Lortholary, et al.. Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network. Journal of Translational Medicine, 2023, 21 (1), pp.408. ⟨10.1186/s12967-023-04264-7⟩. ⟨hal-04390892⟩
• 
  Alice Mogenet, Pascal Finetti, Emilie Denicolai, Laurent Greillier, Pascaline Boudou-Rouquette, et al.. Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer. Journal of Translational Medicine, 2023, 21 (1), pp.637. ⟨10.1186/s12967-023-04463-2⟩. ⟨hal-04390901⟩
• 
  Rossella Libé, Magalie Haissaguerre, Karine Renaudin, Matthieu Faron, Myriam Decaussin-Petrucci, et al.. Impact of lymphovascular invasion on otherwise low-risk papillary thyroid carcinomas: a retrospective and observational study. Bulletin du Cancer, 2023, 110 (10), pp.707 - 730. ⟨10.1016/j.bulcan.2023.03.015⟩. ⟨inserm-04500838⟩
• 
  Klaus Hirschbühl, Myriam Labopin, Emmanuelle Polge, Didier Blaise, Jean Henri Bourhis, et al.. Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years-a registry-based study by the Acute Leukemia Working Party of the EBMT.. Bone Marrow Transplantation, 2023, Bone Marrow Transplantation, ⟨10.1038/s41409-023-01966-w⟩. ⟨hal-04487889⟩
• 
  Thibault Durin, Ugo Marchese, Alain Sauvanet, Safi Dokmak, Zineb Cherkaoui, et al.. Defining Benchmark Outcomes for Distal Pancreatectomy: Results of a French Multicentric Study.. Annals of Surgery, 2023, 278 (1), pp.103-109. ⟨10.1097/SLA.0000000000005539⟩. ⟨hal-03711172⟩
• 
  Kamila Schirmeisen, Karel Naiman, Karine Fréon, Laetitia Besse, Shrena Chakraborty, et al.. SUMO protease and proteasome recruitment at the nuclear periphery differently affect replication dynamics at arrested forks. 2024. ⟨hal-04452867⟩
• 
  Romain Arrestier, Anis Chaba, Asma Mabrouki, Clément Saccheri, Emmanuel Canet, et al.. Necrotizing soft tissue infections in critically ill neutropenic patients: a French multicentre retrospective cohort study. Annals of Intensive Care, 2023, 13 (1), pp.34. ⟨10.1186/s13613-023-01125-w⟩. ⟨hal-04092085⟩
• 
  M Duchmann, B Braun, J.B. Micol, P Platzbecker, P. Park, et al.. Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents. Blood Cancer Journal, 2017, 7 (5), pp.e562. ⟨10.1038/bcj.2017.41⟩. ⟨hal-01655936⟩
• 
  Catherine M. Phelan, Karoline B. Kuchenbaecker, Jonathan Tyrer, Siddhartha Kar, Kate Lawrenson, et al.. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nature Genetics, 2017, 49 (5), pp.680-691. ⟨10.1038/ng.3826⟩. ⟨hal-01778538⟩
• 
  Amira Marouf, Sammara Chaubard, J.M. Michot, Julien Rossignol, Camille Golfier, et al.. S226: EFFICACY OF ANTI-PD1 THERAPY IN RELAPSED OR REFRACTORY EXTRANODAL NK/T CELL LYMPHOMA: A MATCHED COHORT ANALYSIS FROM THE LYSA. HemaSphere, 2023, Hemasphere, 7 (S3), pp.e41118bf. ⟨10.1097/01.hs9.0000967816.41118.bf⟩. ⟨hal-04406218⟩

313

373